**Major Events:**

Silver Nova Medical-B (02591): Hong Kong public offering received 5,341.66 times oversubscription

Stone Four Pharma Group (02005): Azilsartan has received approval from the National Medical Products Administration to be registered as an active pharmaceutical ingredient for use in marketed formulations

RongChang Biopharmaceuticals (09995): Telitacicept (brand name: Tai Ai) for the treatment of primary Sjögren's syndrome achieved the primary endpoint in China Phase III clinical trial

**Operating Performance:**

NTES-S (09999) announced interim results with net profit attributable to the parent company of RMB 18.902 billion, up 31.33% year-on-year

CHINA TELECOM (00728) released interim results with profit attributable to shareholders of RMB 23.017 billion, up 5.52% year-on-year

CHINA TELECOM (00728) reported approximately 282 million 5G network users in the second quarter, with a net increase of 15.81 million users

JD-SW (09618) achieved second-quarter revenue of RMB 356.7 billion, up 22.4% year-on-year, continuing to expand into new growth areas

JD Health (06618) released interim results with revenue up 24.5% year-on-year to RMB 35.29 billion

JD Logistics (02618) announced first-half results with non-IFRS profit reaching RMB 3.3 billion, up 7.1% year-on-year

GEELY AUTO (00175) released interim results with gross profit of RMB 24.719 billion, up 24.41% year-on-year, with first-half sales performance reaching historical highs

CK Hutchison Holdings (00001) announced interim results with reported profit attributable to ordinary shareholders of HK$852 million, down 91.65% year-on-year

CK Asset Holdings (01113) released interim results with profit attributable to shareholders of HK$6.302 billion, down 26.7% year-on-year

MTR Corporation (00066) released interim results with profit attributable to shareholders of HK$7.709 billion, up 27.5% year-on-year, with interim dividend of HK$0.42

LENOVO GROUP (00992) achieved record-high first-quarter revenue with revenue up 22% year-on-year to US$18.8 billion

NETEASE MUSIC (09899) released interim results with profit attributable to shareholders of RMB 1.885 billion, up 132.83% year-on-year

Weibo-SW (09898) announced interim results with net profit attributable to Weibo shareholders of approximately US$233 million, up 44.17% year-on-year

WeiLong (09985) announced interim results with profit attributable to owners of approximately RMB 733 million, up 18% year-on-year

Hysan Development (00014) released interim results with profit attributable to shareholders of HK$75 million, down 82.44% year-on-year

CStone Pharmaceuticals-B (02616) released interim results with R&D expenses of RMB 105 million, up 58.75% year-on-year

CAR-T (Shanghai) Biotechnology-B (02171) announced interim results with net loss of RMB 75.483 million, narrowed by 78.53% year-on-year

GEELY AUTO (00175): Zeekr's second-quarter automotive sales revenue was RMB 22.916 billion, up 2.2% year-on-year and 20.0% quarter-on-quarter

China Coal Energy (01898) reported July commercial coal sales of 21.17 million tons, down 9.6% year-on-year

China Resources Power (00836) reported cumulative electricity sales of approximately 123 million MWh from subsidiary power plants in the first seven months, up 5.4% year-on-year